Incidence of control variables on intention to use. حسب Alessandro Carrera (15226859)

الموضوعات:

Constructs, measurement items, and calculation of Cronbach’s alphas for the proposed model. حسب Alessandro Carrera (15226859)

الموضوعات:

Proposed model and hypotheses (H). حسب Alessandro Carrera (15226859)

الموضوعات:

Overview of the methodology followed. حسب Alessandro Carrera (15226859)

الموضوعات:

Results of path analysis and hypothesis testing of model constructs. حسب Alessandro Carrera (15226859)

الموضوعات:

The goodness of fit indexes of the proposed model. حسب Alessandro Carrera (15226859)

الموضوعات:

Supplementary Figure S2 from PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer حسب Hiroaki Ono (558062)

FIGURE 4 from Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas حسب Andrea R. Daniel (14950305)

Liver Glutathione S-Transferase (GST) activity is decreased by IFNgR signaling. حسب Tamir Diamond (12822347)

الموضوعات:

Caco2 and HUVEC cytokine response curve in traditional 2D culture. حسب Christine Tataru (17628136)

الموضوعات:

Idea and process of this research. حسب Peng Zhang (2071)

"…In this study, the potential therapeutic targets and mechanisms of SAL against oxidative stress in retinal ganglion cells (RGCs) were investigated on the basis of in-vitro experiments, network pharmacology, and molecular docking techniques.…"

Supplementary Figure 2 from Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in <i>EGFR</i> Wild-Type Non–Small Cell Lung Carcinoma Cell Lines حسب Angélique Augustin (15065500)

Figure S6 from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib حسب Lei Zhu (14951404)

Figure S5 from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib حسب Lei Zhu (14951404)

Data Supplement from Centmitor-1, a Novel Acridinyl-Acetohydrazide, Possesses Similar Molecular Interaction Field and Antimitotic Cellular Phenotype as Rigosertib, ON 01910.Na حسب Jenni H.E. Mäki-Jouppila (15067084)

Data Supplement from Centmitor-1, a Novel Acridinyl-Acetohydrazide, Possesses Similar Molecular Interaction Field and Antimitotic Cellular Phenotype as Rigosertib, ON 01910.Na حسب Jenni H.E. Mäki-Jouppila (15067084)

Determination of the splenic IFN- حسب Hedieh Zargaran (21410233)

الموضوعات:

LDH cytotoxicity assay results. حسب Hedieh Zargaran (21410233)

الموضوعات:

Lymphocyte proliferation assay following combination therapy with NDV. حسب Hedieh Zargaran (21410233)

الموضوعات:

Tumor volume measurements. حسب Hedieh Zargaran (21410233)

الموضوعات: